MBX Biosciences CEO Hoerter sells 4,893 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Steven L. Hoerter, MBX Biosciences, Inc.’s Chairman, President and CEO, sold 4,893 shares on November 10, 2026, at a weighted average price of $54.82 per share to cover tax obligations tied to restricted stock unit vesting under a mandatory sell-to-cover agreement. Prices ranged from $51.52 to $55.29 per share, and Hoerter held 78,045 shares directly afterward. The Steven L. Hoerter Revocable Trust dated November 2, 2018 held 20,000 shares; Hoerter serves as trustee and disclaims beneficial ownership except to the extent of any pecuniary interest. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 4,893 | $54.82 | $268K |
| Holding | Common Stock F3 | -- | -- | -- |
Footnotes (3)
- F1. The sales reported on this Form 4 represent shares of common stock sold by the Reporting Person to cover tax obligations in connection with the vesting of restricted stock units, pursuant to a mandatory sell-to-cover agreement between the Reporting Person and the Company.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $51.52 to $55.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. Shares held by the Steven L Hoerter Revocable Trust dated November 2, 2018, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Key Figures
Key Terms
restricted stock units financial
mandatory sell-to-cover agreement financial
weighted average price financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.